Heron Therapeutics (HRTX) Announces U.S. FDA Approval of ZYNRELEF for Management of Postoperative Pain for up to 72 Hours
Go back to Heron Therapeutics (HRTX) Announces U.S. FDA Approval of ZYNRELEF for Management of Postoperative Pain for up to 72 Hours| HERON THERAPEUTICS (NASDAQ: HRTX) | Delayed: 2.55 -0.1 (3.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.65 | 52 Week High | $31.32 | |||
| Open | $2.66 | 52 Week Low | $13.95 | |||
| Day High | $2.66 | P/E | N/A | |||
| Day Low | $2.46 | EPS | $-3.29 | |||
| Volume | 2,197,081 | |||||
